Aug 4, 2021
SoftBank Group Corp. has quietly built a ¥550 billion ($5 billion) stake in Roche Holding AG, placing a bet on the pharmaceutical company’s strategy of using data to develop drugs, according to people familiar with the matter.
The Japanese conglomerate is now one of Roche’s largest investors, according to data compiled by Bloomberg.
Roche’s sales have recently been boosted by its COVID-19 testing business. The company’s diagnostics unit reacted swiftly to the coronavirus pandemic, but the pharmaceuticals division, where aging cancer medicines face increasing competition, has had a more difficult time.
Shares of the Basel, Switzerland-based company have risen 8.8% in the last 12 months, compared with a 14.7% gain in the MSCI World Pharma Biotech & Life Sciences Index over the same period.
SoftBank Builds a $5 Billion Stake in Pharma Giant Roche
This content was published on August 4, 2021 - 07:18
August 4, 2021 - 07:18
(Bloomberg) SoftBank Group Corp. has quietly built a $5 billion stake in Roche Holding AG, placing a bet on the pharmaceutical companyâs strategy of using data to develop drugs, according to people familiar with the matter.
The Japanese conglomerate is now one of Rocheâs largest investors, according to data compiled by Bloomberg.
Rocheâs sales have recently been boosted by its Covid-19 testing business. The companyâs diagnostics unit reacted swiftly to the coronavirus pandemic, but the pharmaceuticals division, where aging cancer medicines face increasing competition, has had a more difficult time.
âAllow Notificationsâ on the message appearing on your browser to activate them. We will send you a quick reminder in the future, in case you change your mind.